Paid Clinical Trials Honolulu
Discover 64 paid clinical trials in Honolulu, Hawaii. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Emovi 3D Knee Assessment Device Intervention for Operational ReadinessEmovi 3D Knee Assessment Device Intervention for Operational Readiness
Sponsor:
Womack Army Medical Center
Location:
Code:
NCT06517056
Conditions
Patellofemoral Pain
Patellofemoral Pain Syndrome
Eligibility Criteria
Sex: All
Age: 18 - 50
Healthy Volunteers: Not accepted
Interventions
Emovi Knee Kinesiography
Genetic RegistryParkinson's Foundation PD GENEration Genetic Registry
Sponsor:
Parkinson's Foundation
Location:
Code:
NCT04994015
Conditions
Parkinson's Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Lab Assay for seven genetic variants for Parkinson's Disease
Tension vs. No TensionTension Versus no Tension With Foley Bulb Induction
Sponsor:
Hawaii Pacific Health
Location:
Code:
NCT03588585
Conditions
Induction of Labor Affected Fetus / Newborn
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tension
NO TENSION
BHV-7000A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures
Sponsor:
Biohaven Therapeutics Ltd.
Location:
Code:
NCT06425159
Conditions
Generalized Epilepsy
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
BHV-7000
Placebo
Num Vapocoolant SprayApplying Num Vapocoolant Spray to Cervix Before Paracervical Block to Decrease Pain During Gynecology Procedures
Sponsor:
Queen's Medical Center
Location:
Code:
NCT06227052
Conditions
Pain With Paracervical Block
Pain With Gynecology Procedure
Pain
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Accepted
Interventions
Num Vapocoolant Spray
Placebo
Immulina TMEffects of Immulina TM Supplements with PASC Patients
Sponsor:
University of Mississippi Medical Center
Location:
Code:
NCT05524532
Conditions
Post Acute COVID-19 Syndrome
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
Immulina TM
Placebo
NaxitamabNaxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Sponsor:
Giselle Sholler
Location:
Code:
NCT05489887
Conditions
High-risk Neuroblastoma
Eligibility Criteria
Sex: All
Age: 12 - 21
Healthy Volunteers: Not accepted
Interventions
Naxitamab
Ceritinib
DFMO & EtoposideEflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
Sponsor:
Giselle Sholler
Location:
Code:
NCT04301843
Conditions
Neuroblastoma
Eligibility Criteria
Sex: All
Age: 0 - 31
Healthy Volunteers: Not accepted
Interventions
Eflornithine
Observational StudyMulticenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT02945579
Conditions
Estrogen Receptor Negative
HER2 Positive Breast Carcinoma
HER2/Neu Negative
Invasive Breast Carcinoma
Progesterone Receptor Negative
Eligibility Criteria
Sex: Female
Age: 30+
Healthy Volunteers: Not accepted
Interventions
Undergo EBRT
Laboratory Biomarker Analysis
Quality-of-Life Assessment
Questionnaire Administration
Partial Breast Irradiation
LuspaterceptELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
Sponsor:
Bristol-Myers Squibb
Location:
Code:
NCT05949684
Conditions
Myelodysplastic Syndromes
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Luspatercept
Epoetin Alfa